Ceftriaxone and Acute Renal Failure in Children

  title={Ceftriaxone and Acute Renal Failure in Children},
  author={Ning Li and Xuefeng Zhou and Ji-yan Yuan and Guiying Chen and Hongliang Jiang and Wen Zhang},
  pages={e917 - e922}
OBJECTIVE: Our aim was to evaluate the clinical profile, treatment, and outcome of ceftriaxone-associated postrenal acute renal failure (PARF) in children. METHODS: We retrospectively studied 31 consecutive cases from 2003 to 2012 for PARF after ceftriaxone treatment. There was no past history of urolithiasis or nephropathy in these children. RESULTS: The average time of ceftriaxone administration before PARF was 5.2 days. The major symptoms apart from anuria included flank pain (>3 years old… 

Figures from this paper

Ceftriaxone-associated nephrolithiasis and gallstone in adults

The findings suggest that the patients' age might play a role in the development of such a complication following CTX administration, and indicates the need for a close monitoring of CTX-treated patients to assess the possible formation of gallstone and nephrolithiasis.

Drug-induced nephrolithiasis and crystalluria: the particular case of the sulfasalazine derivatives

The largest case-series of Mesalazine nephrolithiasis, and the first case of mesalazine crystalluria to date, is reported, which suggests peculiar drug absorption and/or metabolism in these patients.

Characterizing ceftriaxone-induced urolithiasis and its associated acute kidney injury: an animal study and Chinese clinical systematic review

Kidney stones and a significantly low 24-h urine volume with increased high Scr and BUN levels were found in the group that received ceftriaxone combined with calcium and citrate was able to inhibit stone formation and prevent further kidney injury.

Community‐acquired Acute Kidney Injury Among Children Seen in the Pediatric Emergency Department

CA-AKI remains an underrecognized entity in the pediatric emergency department (PED) and better tools for early recognition of AKI in the busy PED environment are needed.

Drug-Induced Urolithiasis in Pediatric Patients

The aim was to perform a comprehensive review of the literature to summarize these drugs and identify the possible mechanisms involved in calculi formation and discuss the management and preventive measures for these calculi.

Drug-Induced Kidney Stones and Crystalline Nephropathy: Pathophysiology, Prevention and Treatment

Diagnosis relies on a careful clinical inquiry to differentiate between common calculi and metabolically induced calculi, of which the incidence is probably underestimated.

Unravelling Pathophysiology of Crystalline Nephropathy in Ceftriaxone-Associated Acute Kidney Injury: A Cellular Proteomic Approach

The in vitro model of crystalline nephropathy is used for the first time to investigate the underlying pathophysiology of ceftriaxone-associated AKI, which should be investigated in vivo for potential clinical benefits in the future.

Pediatric Hematuria Remains a Clinical Dilemma

Hematuria is blood in the urine which can be subclassified relative to appearance (gross vs microscopic), duration (transient, intermittent, or persistent), and/or symptomatic versus asymptomatic.

Ceftriaxone‐associated renal toxicity in adults: a case report and recommendations for the management of such cases

One such case of Ceftriaxone‐associated urolithiasis and post‐renal acute renal failure in adults is reported to increase appreciation of this risk and provide recommendations for its management based on the experience and a review of other similar cases.



Nephrolithiasis associated with ceftriaxone therapy: a prospective study in 51 children

The study showed that children taking a 7 day course of normal or high dose ceftriaxone may develop small sized asymptomatic renal stones.

Ceftriaxone associated nephrolithiasis: a prospective study in 284 children

The results of this study suggest that ceftriaxone-treated patients may be at an increased risk of kidney stone formation, and close monitoring of ceftRIaxone -treated patients with regard to kidneyStone formation is recommended.

Increased urinary calcium excretion caused by ceftriaxone: possible association with urolithiasis

It is suggested that it is worthwhile monitoring the uCa/Cr levels in patients on ceftriaxone as they may be at greater risk for developing large stones and renal damage.

Acute urine retention induced by ceftriaxone.

  • K. AklA. MasriMaali M Hjazeen
  • Medicine
    Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia
  • 2011
A child with acute urinary retention (AUR) secondary to ceftriaxone therapy is reported, and a positive paternal family history of gout and stones is a pointer to the possibility of AUR or urolithiasis in patients on treatment with ceftRIaxone.

Melamine-induced infant urinary calculi: a report on 24 cases and a 1-year follow-up

This series of cases have demonstrated that melamine contained in the “Sanlu” milk powder was the main cause of these urinary stones and urine alkalinization and stone liberalization were the most effective treatments.

Incidence of gallbladder lithiasis after ceftriaxone treatment.

Ceftriaxone treatment does not appear to lead to gallstone formation more often than an antibiotic that is not eliminated through the bile, and gallbladder precipitation that was seen in two patients given ceftriAXone during and at the end of treatment resolved spontaneously.

Ceftriaxone induced hemolysis complicated by acute renal failure

Ceftriaxone is a commonly used drug, and early recognition of haemolytic anemia and institution of supportive care, including dialysis is likely to improve the outcome.

Ceftriaxone‐induced biliary pseudolithiasis and urinary bladder sludge

A case is reported who developed ceftriaxone-induced biliary pseudolithiasis and urinary bladder sludge, which were completely resolved after the ceftRIaxone treatment ceased.

Pediatric ceftriaxone nephrolithiasis.

Ceftriaxone administration has been associated with biliary pseudolithiasis in adult and pediatric patients, and rarely may cause renal and ureteral calculi, and to the authors' knowledge no case has been reported in a child receiving less than the maximum recommended dose of this antibiotic.